Anuncio • May 11
20 Microns Limited to Report Q4, 2026 Results on May 22, 2026 20 Microns Limited announced that they will report Q4, 2026 results on May 22, 2026 Valuation Update With 7 Day Price Move • Apr 06
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹154, the stock trades at a trailing P/E ratio of 8.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 94% over the past three years. Reported Earnings • Jan 25
Third quarter 2026 earnings released: EPS: ₹4.24 (vs ₹3.65 in 3Q 2025) Third quarter 2026 results: EPS: ₹4.24 (up from ₹3.65 in 3Q 2025). Revenue: ₹2.16b (flat on 3Q 2025). Net income: ₹149.6m (up 16% from 3Q 2025). Profit margin: 6.9% (up from 6.0% in 3Q 2025). Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 31% per year, which means it is tracking significantly ahead of earnings growth. Anuncio • Jan 19
20 Microns Limited to Report Q3, 2026 Results on Jan 24, 2026 20 Microns Limited announced that they will report Q3, 2026 results at 4:00 PM, Indian Standard Time on Jan 24, 2026 Reported Earnings • Nov 08
Second quarter 2026 earnings released: EPS: ₹4.92 (vs ₹4.65 in 2Q 2025) Second quarter 2026 results: EPS: ₹4.92 (up from ₹4.65 in 2Q 2025). Revenue: ₹2.32b (down 3.3% from 2Q 2025). Net income: ₹174.0m (up 6.0% from 2Q 2025). Profit margin: 7.5% (up from 6.8% in 2Q 2025). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 31% per year, which means it is tracking significantly ahead of earnings growth. Anuncio • Oct 31
20 Microns Limited to Report Q2, 2026 Results on Nov 07, 2025 20 Microns Limited announced that they will report Q2, 2026 results at 12:08 PM, Indian Standard Time on Nov 07, 2025 Anuncio • Jul 21
20 Microns Limited to Report Q1, 2026 Results on Jul 28, 2025 20 Microns Limited announced that they will report Q1, 2026 results on Jul 28, 2025 Upcoming Dividend • Jul 17
Upcoming dividend of ₹1.25 per share Eligible shareholders must have bought the stock before 24 July 2025. Payment date: 07 September 2025. Payout ratio is a comfortable 7.1% but the company is not cash flow positive. Trailing yield: 0.5%. Lower than top quartile of Indian dividend payers (1.2%). Lower than average of industry peers (0.7%). New Risk • Jul 16
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (22% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.1% average weekly change). Reported Earnings • Jul 12
Full year 2025 earnings released: EPS: ₹17.68 (vs ₹15.89 in FY 2024) Full year 2025 results: EPS: ₹17.68 (up from ₹15.89 in FY 2024). Revenue: ₹9.13b (up 17% from FY 2024). Net income: ₹623.8m (up 11% from FY 2024). Profit margin: 6.8% (down from 7.2% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 46% per year, which means it is tracking significantly ahead of earnings growth. Declared Dividend • May 26
Dividend of ₹1.25 announced Dividend of ₹1.25 is the same as last year. Ex-date: 24th July 2025 Payment date: 7th September 2025 Dividend yield will be 0.5%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (7% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 5.7% per year over the past 8 years. However, payments have been volatile during that time. Earnings per share has grown by 21% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Reported Earnings • May 24
Full year 2025 earnings released: EPS: ₹17.68 (vs ₹15.89 in FY 2024) Full year 2025 results: EPS: ₹17.68 (up from ₹15.89 in FY 2024). Revenue: ₹9.17b (up 18% from FY 2024). Net income: ₹623.8m (up 11% from FY 2024). Profit margin: 6.8% (down from 7.2% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 46% per year, which means it is tracking significantly ahead of earnings growth. Anuncio • May 24
20 Microns Limited announces Annual dividend, payable on September 07, 2025 20 Microns Limited announced Annual dividend of INR 1.2500 per share payable on September 07, 2025, ex-date on July 24, 2025 and record date on July 24, 2025. Anuncio • May 23
20 Microns Limited, Annual General Meeting, Aug 08, 2025 20 Microns Limited, Annual General Meeting, Aug 08, 2025, at 11:00 Indian Standard Time. Anuncio • May 16
20 Microns Limited to Report Q4, 2025 Results on May 23, 2025 20 Microns Limited announced that they will report Q4, 2025 results on May 23, 2025 Valuation Update With 7 Day Price Move • Mar 06
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₹208, the stock trades at a trailing P/E ratio of 12x. Average trailing P/E is 24x in the Chemicals industry in India. Total returns to shareholders of 186% over the past three years. Valuation Update With 7 Day Price Move • Jan 29
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₹194, the stock trades at a trailing P/E ratio of 11.2x. Average trailing P/E is 27x in the Chemicals industry in India. Total returns to shareholders of 116% over the past three years. Anuncio • Jan 23
20 Microns Limited Board Appoints Nihad M. Baluch, as Group CFO with Effect from February 01, 2025 20 Microns Limited Board appointed Mr. Nihad M. Baluch, as Group CFO with effect from February 01, 2025. Nihad M. Baluch is a seasoned senior management professional with over 16 years of diverse experience across multiple industries, including hospitality, infrastructure, textiles, logistics, IT, education, and FMCG. Renowned for providing purpose-driven solutions, Nihad excels in financial and strategic management, business development, and operational excellence. His achievements include spearheading financial growth, project financing, business restructuring, and risk mitigation, ensuring organizations achieve profitability and sustainable growth. Currently working as Group CFO at Dev Salt Pvt. Ltd., Past Experience: CFO at Jindal Texofab Ltd, Group CFO at Dogra Group, CEO at PDMS, FO at Neesa Technologies Ltd. Education: MBA (Finance) from Gujarat University, 2008. BBA (Finance & Marketing) from Gujarat University, 2006. Reported Earnings • Jan 23
Third quarter 2025 earnings released: EPS: ₹3.65 (vs ₹3.25 in 3Q 2024) Third quarter 2025 results: EPS: ₹3.65 (up from ₹3.25 in 3Q 2024). Revenue: ₹2.15b (up 23% from 3Q 2024). Net income: ₹128.9m (up 12% from 3Q 2024). Profit margin: 6.0% (down from 6.6% in 3Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 31% per year, which means it is tracking significantly ahead of earnings growth. Anuncio • Jan 13
20 Microns Limited to Report Q3, 2025 Results on Jan 22, 2025 20 Microns Limited announced that they will report Q3, 2025 results on Jan 22, 2025 Valuation Update With 7 Day Price Move • Dec 04
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₹270, the stock trades at a trailing P/E ratio of 16.1x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 344% over the past three years. New Risk • Nov 12
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₹8.39b (US$99.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (₹8.39b market cap, or US$99.4m). Reported Earnings • Oct 27
Second quarter 2025 earnings released: EPS: ₹4.65 (vs ₹4.54 in 2Q 2024) Second quarter 2025 results: EPS: ₹4.65 (up from ₹4.54 in 2Q 2024). Revenue: ₹2.41b (up 21% from 2Q 2024). Net income: ₹164.1m (up 2.4% from 2Q 2024). Profit margin: 6.8% (down from 8.0% in 2Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 70% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Oct 18
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹306, the stock trades at a trailing P/E ratio of 18.3x. Average trailing P/E is 36x in the Chemicals industry in India. Total returns to shareholders of 431% over the past three years. Anuncio • Oct 15
20 Microns Limited to Report Q2, 2025 Results on Oct 25, 2024 20 Microns Limited announced that they will report Q2, 2025 results at 12:08 PM, Indian Standard Time on Oct 25, 2024 Recent Insider Transactions • Aug 07
Non-Executive Independent Director recently sold ₹1.2m worth of stock On the 5th of August, Ramkisan Devidayal sold around 4k shares on-market at roughly ₹289 per share. This transaction amounted to 7.0% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth ₹7.2m. Insiders have been net sellers, collectively disposing of ₹16m more than they bought in the last 12 months. Reported Earnings • Jul 27
First quarter 2025 earnings released: EPS: ₹5.06 (vs ₹4.23 in 1Q 2024) First quarter 2025 results: EPS: ₹5.06 (up from ₹4.23 in 1Q 2024). Revenue: ₹2.32b (up 22% from 1Q 2024). Net income: ₹178.6m (up 20% from 1Q 2024). Profit margin: 7.7% (down from 7.8% in 1Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has increased by 57% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Jul 26
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ₹258, the stock trades at a trailing P/E ratio of 16.2x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 292% over the past three years. Anuncio • Jul 23
20 Microns Limited Declares Final Dividend for the Fiscal Year 2023-2024 20 Microns Limited announced that at the AGM held on July 19, 2024, declared final dividend is 25% i.e. INR 1.25 per equity share on 35,286,502 equity shares of the Face Value of INR 5/- each for the financial year 2023-24. Anuncio • Jul 16
20 Microns Limited to Report Q1, 2025 Results on Jul 26, 2024 20 Microns Limited announced that they will report Q1, 2025 results on Jul 26, 2024 Upcoming Dividend • Jul 05
Upcoming dividend of ₹1.25 per share Eligible shareholders must have bought the stock before 12 July 2024. Payment date: 18 August 2024. Payout ratio is a comfortable 7.9% and this is well supported by cash flows. Trailing yield: 0.5%. Lower than top quartile of Indian dividend payers (1.1%). Lower than average of industry peers (0.7%). Valuation Update With 7 Day Price Move • Jun 27
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ₹223, the stock trades at a trailing P/E ratio of 14x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 278% over the past three years. Recent Insider Transactions • Jun 25
Non-Executive Independent Director recently sold ₹7.2m worth of stock On the 21st of June, Ramkisan Devidayal sold around 35k shares on-market at roughly ₹206 per share. This transaction amounted to 38% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹15m more than they bought in the last 12 months. Reported Earnings • Jun 23
Full year 2024 earnings released: EPS: ₹15.89 (vs ₹11.85 in FY 2023) Full year 2024 results: EPS: ₹15.89 (up from ₹11.85 in FY 2023). Revenue: ₹7.78b (up 11% from FY 2023). Net income: ₹560.7m (up 34% from FY 2023). Profit margin: 7.2% (up from 6.0% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has increased by 51% per year, which means it is tracking significantly ahead of earnings growth. Anuncio • May 23
20 Microns Limited, Annual General Meeting, Jul 19, 2024 20 Microns Limited, Annual General Meeting, Jul 19, 2024. Reported Earnings • May 18
Full year 2024 earnings released: EPS: ₹15.89 (vs ₹11.85 in FY 2023) Full year 2024 results: EPS: ₹15.89 (up from ₹11.85 in FY 2023). Revenue: ₹7.82b (up 11% from FY 2023). Net income: ₹560.7m (up 34% from FY 2023). Profit margin: 7.2% (up from 6.0% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has increased by 44% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • May 16
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹188, the stock trades at a trailing P/E ratio of 12.8x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 190% over the past three years. Buy Or Sell Opportunity • May 02
Now 21% undervalued Over the last 90 days, the stock has risen 3.5% to ₹169. The fair value is estimated to be ₹213, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 26%. Buy Or Sell Opportunity • Feb 05
Now 21% undervalued The stock has been flat over the last 90 days, currently trading at ₹158. The fair value is estimated to be ₹199, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 26%. Reported Earnings • Jan 29
Third quarter 2024 earnings released: EPS: ₹3.25 (vs ₹2.09 in 3Q 2023) Third quarter 2024 results: EPS: ₹3.25 (up from ₹2.09 in 3Q 2023). Revenue: ₹1.75b (up 13% from 3Q 2023). Net income: ₹114.8m (up 56% from 3Q 2023). Profit margin: 6.6% (up from 4.8% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 65% per year, which means it is tracking significantly ahead of earnings growth. Recent Insider Transactions • Dec 27
Non-Executive Independent Director recently sold ₹976k worth of stock On the 22nd of December, Ramkisan Devidayal sold around 5k shares on-market at roughly ₹195 per share. This transaction amounted to 4.7% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth ₹1.9m. Insiders have been net sellers, collectively disposing of ₹3.3m more than they bought in the last 12 months. Recent Insider Transactions • Nov 28
Non-Executive Independent Director recently sold ₹1.9m worth of stock On the 23rd of November, Ramkisan Devidayal sold around 11k shares on-market at roughly ₹174 per share. This transaction amounted to 9.2% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Reported Earnings • Oct 27
Second quarter 2024 earnings released: EPS: ₹4.54 (vs ₹3.37 in 2Q 2023) Second quarter 2024 results: EPS: ₹4.54 (up from ₹3.37 in 2Q 2023). Revenue: ₹2.01b (up 6.7% from 2Q 2023). Net income: ₹160.3m (up 35% from 2Q 2023). Profit margin: 8.0% (up from 6.3% in 2Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has increased by 68% per year, which means it is tracking significantly ahead of earnings growth. Buying Opportunity • Oct 18
Now 21% undervalued Over the last 90 days, the stock is up 38%. The fair value is estimated to be ₹177, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 32%. Anuncio • Oct 14
20 Microns Limited to Report Q2, 2024 Results on Oct 25, 2023 20 Microns Limited announced that they will report Q2, 2024 results on Oct 25, 2023 Valuation Update With 7 Day Price Move • Oct 05
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₹154, the stock trades at a trailing P/E ratio of 12.5x. Average trailing P/E is 27x in the Chemicals industry in India. Total returns to shareholders of 456% over the past three years. Anuncio • Aug 11
20 Microns Limited Approves Final Dividend for the Financial Year Ended 31 March, 2023 20 Microns Limited announced that at the Annual General Meeting held on August 10, 2023, approved to declare a final dividend on Equity shares at INR 0.75 (15%) per share for the financial year ended 31st March, 2023. Buying Opportunity • Jul 31
Now 20% undervalued Over the last 90 days, the stock is up 38%. The fair value is estimated to be ₹146, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 32%. Reported Earnings • Jul 21
Full year 2023 earnings released: EPS: ₹11.85 (vs ₹9.80 in FY 2022) Full year 2023 results: EPS: ₹11.85 (up from ₹9.80 in FY 2022). Revenue: ₹7.02b (up 14% from FY 2022). Net income: ₹418.2m (up 21% from FY 2022). Profit margin: 6.0% (up from 5.6% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has increased by 48% per year, which means it is tracking significantly ahead of earnings growth. Upcoming Dividend • Jul 19
Upcoming dividend of ₹0.75 per share at 0.7% yield Eligible shareholders must have bought the stock before 26 July 2023. Payment date: 09 September 2023. Trailing yield: 0.7%. Lower than top quartile of Indian dividend payers (1.5%). Lower than average of industry peers (0.9%). Anuncio • Jul 12
20 Microns Limited to Report Q1, 2024 Results on Jul 21, 2023 20 Microns Limited announced that they will report Q1, 2024 results on Jul 21, 2023 Valuation Update With 7 Day Price Move • May 25
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₹97.85, the stock trades at a trailing P/E ratio of 8.3x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 275% over the past three years. Reported Earnings • May 19
Full year 2023 earnings released: EPS: ₹11.85 (vs ₹9.80 in FY 2022) Full year 2023 results: EPS: ₹11.85 (up from ₹9.80 in FY 2022). Revenue: ₹7.05b (up 15% from FY 2022). Net income: ₹418.2m (up 21% from FY 2022). Profit margin: 5.9% (up from 5.6% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has increased by 48% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Apr 03
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹74.30, the stock trades at a trailing P/E ratio of 6.1x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 204% over the past three years. Anuncio • Jan 13
20 Microns Limited to Report Q3, 2023 Results on Jan 25, 2023 20 Microns Limited announced that they will report Q3, 2023 results on Jan 25, 2023 Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 5 highly experienced directors. Non-Executive Independent Director Jaideep Verma was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Recent Insider Transactions • Aug 08
Insider recently sold ₹1.2m worth of stock On the 5th of August, Raghuveer Devidayal sold around 11k shares on-market at roughly ₹102 per share. In the last 3 months, they made an even bigger sale worth ₹1.2m. Insiders have been net sellers, collectively disposing of ₹12m more than they bought in the last 12 months. Valuation Update With 7 Day Price Move • Aug 05
Investor sentiment improved over the past week After last week's 20% share price gain to ₹108, the stock trades at a trailing P/E ratio of 8.2x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 207% over the past three years. Reported Earnings • Jul 30
First quarter 2023 earnings released: EPS: ₹3.76 (vs ₹1.64 in 1Q 2022) First quarter 2023 results: EPS: ₹3.76 (up from ₹1.64 in 1Q 2022). Net income: ₹132.6m (up 129% from 1Q 2022). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 39% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Jun 30
Full year 2022 earnings released: EPS: ₹9.80 (vs ₹6.51 in FY 2021) Full year 2022 results: EPS: ₹9.80 (up from ₹6.51 in FY 2021). Revenue: ₹6.13b (up 27% from FY 2021). Net income: ₹345.9m (up 51% from FY 2021). Profit margin: 5.6% (up from 4.8% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 21% per year, which means it is tracking significantly ahead of earnings growth. Anuncio • Jun 29
20 Microns Limited to Report Fiscal Year 2023 Results on May 30, 2023 20 Microns Limited announced that they will report fiscal year 2023 results on May 30, 2023 Recent Insider Transactions • May 21
Insider recently sold ₹1.2m worth of stock On the 18th of May, Raghuveer Devidayal sold around 14k shares on-market at roughly ₹86.34 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹9.8m more than they bought in the last 12 months. Reported Earnings • May 05
Full year 2022 earnings released: EPS: ₹9.80 (vs ₹6.51 in FY 2021) Full year 2022 results: EPS: ₹9.80 (up from ₹6.51 in FY 2021). Revenue: ₹6.15b (up 27% from FY 2021). Net income: ₹345.9m (up 51% from FY 2021). Profit margin: 5.6% (up from 4.8% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 38% per year, which means it is tracking significantly ahead of earnings growth. Board Change • Apr 27
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 2 experienced directors. 4 highly experienced directors. Non-Executive Independent Director Jaideep Verma was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Apr 05
Investor sentiment improved over the past week After last week's 18% share price gain to ₹85.75, the stock trades at a trailing P/E ratio of 9.3x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 129% over the past three years. Recent Insider Transactions • Jan 31
Non-Executive Independent Director recently sold ₹1.9m worth of stock On the 28th of January, Atulbhai Patel sold around 20k shares on-market at roughly ₹97.41 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹459k more than they bought in the last 12 months. Reported Earnings • Jan 25
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: EPS: ₹4.94 (up from ₹1.60 in 3Q 2021). Revenue: ₹1.61b (up 7.5% from 3Q 2021). Net income: ₹116.4m (up 106% from 3Q 2021). Profit margin: 7.2% (up from 3.8% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 36% per year, which means it is tracking significantly ahead of earnings growth. Board Change • Dec 06
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 2 experienced directors. 4 highly experienced directors. Non-Executive Independent Director Jaideep Verma was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Recent Insider Transactions • Nov 21
Non-Executive Independent Director recently bought ₹301k worth of stock On the 18th of November, Ajay Ranka bought around 5k shares on-market at roughly ₹60.13 per share. In the last 3 months, they made an even bigger purchase worth ₹1.3m. Despite this recent purchase, insiders have collectively sold ₹282k more in shares than they bought in the last 12 months. Recent Insider Transactions • Nov 11
Non-Executive Independent Director recently bought ₹1.3m worth of stock On the 8th of November, Ajay Ranka bought around 21k shares on-market at roughly ₹59.35 per share. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold ₹884k more in shares than they bought in the last 12 months. Reported Earnings • Oct 23
Second quarter 2022 earnings released: EPS ₹1.85 (vs ₹2.81 in 2Q 2021) The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2022 results: Revenue: ₹1.63b (up 27% from 2Q 2021). Net income: ₹65.3m (down 23% from 2Q 2021). Profit margin: 4.0% (down from 6.6% in 2Q 2021). The decrease in margin was driven by higher expenses. 
